Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,073 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiotherapy Combined with a Radiosensitizer for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Carcinoma In Situ Bladder Cancer: An Open-label, Single-arm, Multicenter, Phase 2 European Organisation for Research and Treatment of Cancer Trial.
Achard V, Fournier B, D'Haese D, Krzystyniak J, Tombal B, Roupret M, Sargos P, Dirix P. Achard V, et al. Among authors: roupret m. Eur Urol Oncol. 2024 Oct;7(5):982-985. doi: 10.1016/j.euo.2024.03.008. Epub 2024 Mar 30. Eur Urol Oncol. 2024. PMID: 38556413
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group.
Marcq G, Afferi L, Neuzillet Y, Nykopp T, Voskuilen CS, Furrer MA, Kassouf W, Aziz A, Bajeot AS, Alvarez-Maestro M, Black P, Roupret M, Noon AP, Seiler R, Hendricksen K, Roumiguie M, Pang KH, Laine-Caroff P, Xylinas E, Ploussard G, Moschini M, Sargos P; YAU Urothelial Group. Marcq G, et al. Among authors: roupret m. Cancers (Basel). 2022 Nov 22;14(23):5740. doi: 10.3390/cancers14235740. Cancers (Basel). 2022. PMID: 36497222 Free PMC article.
A Systematic Review of Oncological Outcomes Associated with Bladder-sparing Strategies in Patients Achieving Complete Clinical Response to Initial Systemic Treatment for Localized Muscle-invasive Bladder Cancer.
Grobet-Jeandin E, Lenfant L, Mir C, Giannarini G, Alcaraz A, Albersen M, Breda A, Briganti A, Rouprêt M, Seisen T; EAU Section of Oncological Urology (ESOU) Board. Grobet-Jeandin E, et al. Among authors: roupret m. Eur Urol Oncol. 2023 Jun;6(3):251-262. doi: 10.1016/j.euo.2023.02.008. Epub 2023 Mar 9. Eur Urol Oncol. 2023. PMID: 36906510 Review.
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty.
Bamias A, Stenzl A, Brown SL, Albiges L, Babjuk M, Birtle A, Briganti A, Burger M, Choudhury A, Colecchia M, De Santis M, Fanti S, Fonteyne V, Gallucci M, Rivas JG, Huddart R, Junker K, Kroeze S, Loriot Y, Merseburger A, Montironi R, Necchi A, Oing C, Oldenburg J, Ost P, Pinkawa M, Ribal MJ, Rouprêt M, Thoeny H, Zilli T, Hoskin P. Bamias A, et al. Among authors: roupret m. Eur Urol. 2023 Oct;84(4):381-389. doi: 10.1016/j.eururo.2023.05.005. Epub 2023 May 20. Eur Urol. 2023. PMID: 37217391
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy.
Wu Z, Chen H, Chen Q, Ge S, Yu N, Campi R, Gómez Rivas J, Autorino R, Rouprêt M, Psutka SP, Mehrazin R, Porpiglia F, Bensalah K, Black PC, Mir MC, Minervini A, Djaladat H, Margulis V, Bertolo R, Caliò A, Carbonara U, Amparore D, Borregales LD, Ciccarese C, Diana P, Erdem S, Marandino L, Marchioni M, Muselaers CHJ, Palumbo C, Pavan N, Pecoraro A, Roussel E, Warren H, Pandolfo SD, Chen R, Zhou W, Zhai W, He M, Li Y, Han B, Wan J, Zeng X, Yan J, Fu Y, Ji C, Fan X, Zhang G, Zhao C, Jing T, Wang A, Feng C, Zhao H, Sun D, Wang L, Tai S, Zhang C, Chen S, Liu Y, Xu Z, Wang H, Gao J, Wang F, Cheng J, Miao H, Rao Q, Wang J, Xu N, Wang G, Liang C, Liu Z, Xia D, Jiang J, Zu X, Chen M, Guo H, Qin W, Wang Z, Xue W, Shi B, Zhou X, Wang S, Zheng J, Ge J, Feng X, Li M, Chen C, Qu L, Wang L; REMEMBER Consortium and the European Association of Urology Young Academic Urologists Renal Cancer Working Group. Wu Z, et al. Among authors: roupret m. Eur Urol Oncol. 2024 Feb;7(1):112-121. doi: 10.1016/j.euo.2023.06.006. Epub 2023 Jul 18. Eur Urol Oncol. 2024. PMID: 37468393
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer.
Catto JWF, Tran B, Rouprêt M, Gschwend JE, Loriot Y, Nishiyama H, Redorta JP, Daneshmand S, Hussain SA, Cutuli HJ, Procopio G, Guadalupi V, Vasdev N, Naini V, Crow L, Triantos S, Baig M, Steinberg G; THOR-2 Cohort 1 Investigators. Catto JWF, et al. Among authors: roupret m. Ann Oncol. 2024 Jan;35(1):98-106. doi: 10.1016/j.annonc.2023.09.3116. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871701 Free article. Clinical Trial.
1,073 results